A pooled analysis of case-control studies on glioma and use of mobile phones and cordless phones was conducted in Sweden.
Following studies are included: The first case-control study covering the period 1997-2000 was published in the publications Hardell et al (2002) and Hardell et al (2003). The second study covering the period 2000-2003 was published in Hardell et al (2005) concerning benign brain tumors and in Hardell et al (2006) concerning malignant brain tumors. A pooled analysis of these studies is published in Hardell et al (2006). The new case-control study on brain tumors was conducted in the period 2007-2009. The results of this new study on meningioma are published in Carlberg et al (2013). The results of the pooled analysis for acoustic neuroma, 1997-2003 and 2007-2009, is available in the publication Hardell et al (2013).
Group | Description |
---|---|
Reference group 1 | unexposed |
Group 2 | analog mobile phone > 1 year latency period |
Group 3 | analog mobile phone > 1- to 5-year latency period |
Group 4 | analog mobile phone > 5- to 10-year latency period |
Group 5 | analog mobile phone > 10- to 15-year latency period |
Group 6 | analog mobile phone > 15- to 20-year latency period |
Group 7 | analog mobile phone > 20- to 25- year latency period |
Group 8 | analog mobile phone > 25 year latency period |
Group 9 | digital (2G) mobile phone > 1 year latency period |
Group 10 | digital (2G) mobile phone > 1- to 5-year latency period |
Group 11 | digital (2G) mobile phone > 5- to 10-year latency period |
Group 12 | digital (2G) mobile phone > 10- to 15-year latency period |
Group 13 | digital (2G) mobile phone > 15- to 20-year latency period |
Group 14 | digital (3G) mobile phone > 1 year latency period |
Group 15 | digital (3G) mobile phone > 1- to 5-year latency period |
Group 16 | digital (3G) mobile phone > 5- to 10-year latency period |
Group 17 | analog + digital mobile phone > 1 year latency period |
Group 18 | analog + digital mobile phone > 1- to 5-year latency period |
Group 19 | analog + digital mobile phone > 5- to 10-year latency period |
Group 20 | analog + digital mobile phone > 10- to 15-year latency period |
Group 21 | analog + digital mobile phone > 15- to 20-year latency period |
Group 22 | analog + digital mobile phone > 20-to 25-year latency period |
Group 23 | analog + digital mobile phone > 25 -year latency period |
Group 24 | cordless phone > 1 year latency period |
Group 25 | cordless phone > 1- to 5-year latency period |
Group 26 | cordless phone > 5- to 10-year latency period |
Group 27 | cordless phone > 10- to 15-year latency period |
Group 28 | cordless phone > 15- to 20-year latency period |
Group 29 | cordless phone > 20- to 25-year latency period |
Group 30 | digital phone (2G, 3G and/or cordless phone) > 1 year latency period |
Group 31 | digital phone (2G, 3G and/or cordless phone) > 1- to 5-year latency period |
Group 32 | digital phone (2G, 3G and/or cordless phone) > 5- to 10-year latency period |
Group 33 | digital phone (2G, 3G and/or cordless phone) > 10- to 15-year latency period |
Group 34 | digital phone (2G, 3G and/or cordless phone) > 10- to 15-year latency period |
Group 35 | digital phone (2G, 3G and/or cordless phone) > 20- to 25- year latency period |
Group 36 | mobile phone + cordless phone > 1 year latency period |
Group 37 | mobile phone + cordless phone > 1- to 5-year latency period |
Group 38 | mobile phone + cordless phone > 5- to 10-year latency period |
Group 39 | mobile phone + cordless phone > 10- to 15-year latency period |
Group 40 | mobile phone + cordless phone > 15- to 20-year latency period |
Group 41 | mobile phone + cordless phone > 20- to 25-year latency period |
Group 42 | mobile phone + cordless phone > 20-year latency period |
Cases | Controls | |
---|---|---|
Eligible | 1,691 | 4,038 |
Participants | 1,498 | 3,530 |
Participation rate | 89 % | 87 % |
1380 patients with glioma
Mobile phone use increased the risk of glioma (group 17: OR 1.3, CI 1.1-1.6), increasing to OR 3.0 (CI 1.7-5.2) in the > 25 year latency group. An increased risk was observed with the use of cordless phones (group 24: OR 1.4, CI 1.1-1.7), with highest risk in the >15-20 year latency group (group 28: OR 1.7, CI 1.1-2.5). The OR increased statistically significant both per 100 h of cumulative use (OR 1.011, CI 1.008-1.014), and per year of latency for mobile and cordless phone use (OR 1.032, CI 1.019-1.046). An increased risk was found for ipsilateral mobile phone use (OR 1.8, CI 1.4-2.2) and cordless phone use (OR 1.7, CI 1.3-2.1). First use of mobile before the age of 20 gave higher OR (OR 1.8, CI 1.2-2.8) for glioma than in later age groups (20-49 years: OR 1.3, CI 1.1-1.6; 50 years and older: OR 1.3, KI 1.1-1.6); similar results were observed for cordless phone use.
The authors conclude that this pooled analysis gives further support that mobile phone and cordless phone use increases the risk for glioma.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.